HTA, Economic Evaluation, Pricing and Reimbursement, Market Access
Consulting on Market Access
  • » To design strategic action plans on the utilization
        of clinical and economic evidences and on how
        to advertise it to decision-makers, considering
        the central/national and local/regional contexts
        of negotiation (regional providers of care: hospitals,
        specialists or medical practitioners, nursing, etc.)
  • » To develop scenario analyses useful to simulate
        the placing in therapy of a new product, or to simulate
        the effects of external factors in the market
        competition, which may affect the profits from the
        product (for example: the introduction of new drugs
        or the patent's expiration of a competitor)
  • » To develop health economic analysis or budget impact
        analysis on the National or Regional Health Services
  • » To analyze data on monitoring of pharmaceutical
        consumption and sales